Pyrimido[4,5-b]quinolin-2-amine, 7-methoxy-(582334-06-3)
- Name: Pyrimido[4,5-b]quinolin-2-amine, 7-methoxy-
- Synonyms:
- Molecular Formula:C12H10N4O
- Molecular Weight:
- CAS Registry Number:582334-06-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.582334-06-3 7-Methoxypyrimido[4,5-b]quinolin-2-amine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 582333-86-6/2(1H)-Pyrimidinethione, 5,6-dihydro-4-methyl-6-(4-methylphenyl)-5-(1,8-naphthyridin-2-yl)-
- 582333-87-7/2(1H)-Pyrimidinethione, 5,6-dihydro-6-(4-methoxyphenyl)-4-methyl-5-(1,8-naphthyridin-2-yl)-
- 582333-88-8/2(1H)-Pyrimidinethione, 6-(2-chlorophenyl)-5,6-dihydro-4-methyl-5-(1,8-naphthyridin-2-yl)-
- 582333-89-9/2(1H)-Pyrimidinethione, 6-(4-chlorophenyl)-5,6-dihydro-4-methyl-5-(1,8-naphthyridin-2-yl)-
- 582333-90-2/2(1H)-Pyrimidinethione, 5,6-dihydro-6-(2-hydroxyphenyl)-4-methyl-5-(1,8-naphthyridin-2-yl)-
- 582333-91-3/2(1H)-Pyrimidinethione, 5,6-dihydro-6-(4-hydroxyphenyl)-4-methyl-5-(1,8-naphthyridin-2-yl)-
- 582333-92-4/2(1H)-Pyrimidinethione, 6-[4-(dimethylamino)phenyl]-5,6-dihydro-4-methyl-5-(1,8-naphthyridin-2- yl)-
- 582333-93-5/1H-1,5-Benzodiazepine, 2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-2-phenyl-
- 582333-94-6/1H-1,5-Benzodiazepine, 2,3-dihydro-4-methyl-2-(4-methylphenyl)-3-(1,8-naphthyridin-2-yl)-
- 582333-95-7/1H-1,5-Benzodiazepine, 2,3-dihydro-2-(4-methoxyphenyl)-4-methyl-3-(1,8-naphthyridin-2-yl)-
- 582333-96-8/1H-1,5-Benzodiazepine, 2-(2-chlorophenyl)-2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-
- 582333-97-9/1H-1,5-Benzodiazepine, 2-(4-chlorophenyl)-2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-
- 582333-98-0/Phenol, 2-[2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-1H-1,5-benzodiazepin -2-yl]-
- 582333-99-1/Phenol, 4-[2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-1H-1,5-benzodiazepin -2-yl]-
- 582334-00-7/Benzenamine, 4-[2,3-dihydro-4-methyl-3-(1,8-naphthyridin-2-yl)-1H-1,5-benzodiazepin -2-yl]-N,N-dimethyl-
- 582334-02-9/Pyrimido[4,5-b]quinolin-2-amine
- 582334-03-0/Pyrimido[4,5-b]quinolin-2-amine, 9-methyl-
- 582334-04-1/Pyrimido[4,5-b]quinolin-2-amine, 7-methyl-
- 582334-05-2/Pyrimido[4,5-b]quinolin-2-amine, 9-methoxy-
- 582334-06-3/Pyrimido[4,5-b]quinolin-2-amine, 7-methoxy-
- 582334-08-5/Ethanimidamide, N,N'-bis[2,6-bis(1-methylethyl)phenyl]-
- 582334-09-6/Cyclopentanone, 3-(4-chlorophenyl)-4-(1-methyl-1-phenylethoxy)-, (3R,4S)-
- 582334-10-9/2-Cyclopenten-1-one, 4-(4-chlorophenyl)-, (4S)-
- 582334-11-0/2-Cyclopenten-1-ol, 4-(4-chlorophenyl)-, (4S)-
- 582334-12-1/2-Furanol, 4-(4-chlorophenyl)tetrahydro-, (4R)-
- 58234-16-5/DL-Alanine, N-acetyl-N-(2,6-dimethylphenyl)-, methyl ester
- 5823-53-0/1,14-Dithia-2,13,15,26-tetraazacyclohexacosane, 1,1,14,14-tetraoxide
- 58236-19-4/1-Anthracenecarboxylic acid, 6,7-dichloro-9,10-dihydro-9,10-dioxo-
- 58236-24-1/1-Anthracenecarboxylic acid, 5-chloro-9,10-dihydro-
- 58236-77-4/2-Propenoic acid, 3-[3-chloro-4-(1-methylethoxy)phenyl]-